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Protein kinase CLung surfactant secretion involves lamellar body docking and fusion with the plasma membrane in alveolar
type II cells. Annexin A7 (A7) is postulated to play a role in membrane fusion during exocytosis. Our recent
studies demonstrated increased co-localization of A7 with ABCA3 in lamellar bodies in type II cells stimulated
with established secretagogues of lung surfactant. In this study, we investigated in vivo and in vitro interactions
of A7 with the t-SNARE protein, SNAP23. Immuno-ﬂuorescence studies showed time-dependent increases in
co-localization of A7 with SNAP23 in PMA- and in A23187-stimulated cells. PMA and A23187 also caused a
time-dependent increase in co-localization of ABCA3 with SNAP23. The relocation of A7 to SNAP23 domains
was inhibited in the presence of PKC inhibitor, similar to that previously reported for co-localization of A7
with ABCA3. The interaction of A7 and SNAP23 was conﬁrmed by afﬁnity binding and by in vitro interaction
of recombinant A7 and SNAP23 proteins. The in vitro binding of recombinant A7 (rA7) to GST-SNAP23 fusion
protein was calcium-dependent. Phosphorylation of rA7 with PKC increased its in vitro binding to SNAP23
suggesting that a similar mechanism may operate during A7 relocation to t-SNARE domains. Thus, our studies
demonstrate that annexin A7 may function in co-ordination with SNARE proteins and that protein kinase acti-
vation may be required for annexin A7 trafﬁcking to the interacting membranes (lamellar bodies and plasma
membrane) to facilitate membrane fusion during surfactant secretion.
© 2012 Elsevier B.V. All rights reserved.1 . Introduction
Lung surfactant facilitates gas-exchange in the lung by lowering
surface tension at air–liquid interface during end-expiration and
prevents lung collapse. The principal component, phosphatidylcholine,
together with surfactant proteins B and C is required for lowering of
surface tension. All of these components are synthesized in alveolar
type II cells. The surfactant storage organelles, lamellar bodies, must
fuse with the apical plasma membrane in type II cells for surfactant
secretion into the alveolar space. Although several agents promote
lung surfactant secretion, and intracellular signalingmediating secretion
has been extensively investigated [1–3], the mechanisms that regulate
such membrane fusion have been relatively poorly investigated. We
have previously shown that one of the annexin proteins, annexin A7
(A7), can facilitate membrane fusion between lamellar bodies and plas-
ma membrane in vitro [4] and that A7 can promote surfactant secretion
in semi-permeable alveolar type II cells [5]. More recently, our in vitro
studies suggested that diacylglycerol could regulate A7 function during
membrane fusion, since lamellar body enrichment with diacylglycerol
increased the A7-mediated membrane fusion activity [6].11-050, Health Sciences Center,
1; fax: +1 631 444 9142.
nder).
l rights reserved.Intracellular membrane fusion studies have suggested involvement
of soluble N-ethylmaleimide-sensitive fusion protein attachment
receptors (SNARE) proteins (reviewed in [7–10]). Previous studies
have deﬁned the role of SNARE proteins complex, including the vesicle
(v)-SNARE (synaptic vesicle-associatedmembrane protein, VAMP) and
target (t)-SNARE (members of syntaxin and SNAP families), in synaptic
transmission or during intracellular trafﬁcking of proteins from the
Golgi. These studies suggested an important role for the SNARE
complex in docking of secretory vesicles on the target membrane. At
the fusion site, cognate SNARE members can pair to allow ‘zippering’
for close apposition of the two fusing membranes [11]. Recent in
vitro studies have demonstrated that proteins of SNARE complex are
capable of causing vesicle fusion when incorporated into lipid vesicles
[12]. However, studies in knockout animals lacking SNARE proteins
SNAP25 [13] and VAMP2 [14] suggested that SNAREs may not be
essential for fusion. Therefore, it is possible that other proteins may
function during membrane fusion either independently or together
with SNARE proteins. We and others have proposed a role for annexin
proteins in membrane fusion during surfactant secretion in alveolar
type II cells. Lipid vesicle fusion can also be facilitated by at least two
of the annexin proteins, annexin A2 [15,16] and A7 [17–19]. Some of
the SNARE proteins are also postulated to play a role in lung surfactant
secretion [20]. This study demonstrated that syntaxin2 is predominant-
ly present in plasma membrane while SNAP23 was present in both the
lamellar bodies and plasma membranes. Although this study proposed
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duced from co-localization studies [21], the regulatory mechanisms
controlling such interactions were not investigated.
We have previously postulated that A7 binding to lamellar bodies
or plasma membrane would facilitate the membrane fusion [19]. We
reported preferential binding of puriﬁed bovine A7 to isolated lamellar
bodies and plasma membrane fractions [22]. The binding to plasma
membrane or lamellar bodies from secretagogue-stimulated cells was
higher in comparison to the fractions from untreated cells [22]. In our
recent studies, we demonstrated that surfactant secretagogues pro-
moted A7 relocation to the lamellar bodies in alveolar type II cells
and that such relocation was regulated by protein kinase activation
[23]. In the current study, we investigated if two of the surfactant se-
cretagogues (phorbol myristate acetate, PMA, and calcium ionophore
A23187) also increased relocation of A7 to the t-SNARE containing
domains in type II cells. Our studies demonstrate that both agents in-
crease A7 co-localization with the t-SNARE protein SNAP23 in type II
cells. The ATP-Binding Cassette A3 (ABCA3) protein in lamellar body
membranes [24,25] also showed co-localization with SNAP23, which
was increased with cell-stimulation. As demonstrated previously for
A7 and ABCA3 co-localization, BisI (a PKC inhibitor) blocked increased
co-localization of cell A7 with SNAP23. In vitro binding showed that
calcium and protein phosphorylation regulated binding of A7 to
SNAP23. Thus, our studies support that increased membrane-
association of A7 in domains containing t-SNARE proteins is facilitated
by protein kinase activation, which may control membrane fusion dur-
ing secretion.
2. Methods
2.1. Isolation of alveolar type II cells
The use of animals for studies reported here was approved by the
institutional animal care and use committee. Rat lung epithelial type
II cells were isolated as described previously. Brieﬂy, anesthetized
(Nembutal, 50 mg/kg, ip) adult Sprague–Dawley male rats (200–
300 g, body weight) were tracheostomized and ventilated with a
rodent ventilator. Following sacriﬁce by exsanguination, the lungs
were visibly cleared of residual blood by perfusion through the pulmo-
nary artery. Lungs along with the trachea were excised and intra-
tracheally treated with porcine elastase (3 units/ml, Worthington,
Lakewood, NJ) for protease digestion of lungs for isolation of alveolar
type II cells as described previously [26]. After elastase incubations,
lung lobes were minced on a tissue-chopper, and the lung mince was
shaken vigorously to release free cells that showed enrichment with
alveolar type II cells. The contaminating macrophages were removed
by adherence to rat serum IgG-coated bacteriological plates. The
resulting free cells showing ~90% purity of type II cells (by acridine or-
ange staining [27]) were suspended in minimum essential medium
(MEM) containing 10% fetal bovine serum (FBS) and cultured for
20–22 h in tissue culture plastic dishes or on glass cover slips. The adher-
ent cells at the end of this culture period show >95% purity with type II
cells and >97% of the cells routinely exclude Trypan Blue. Adherent type
II cells were used for all studies reported here.
2.2. Cell treatment with agents
Following culture of type II cells for 20–22 h, the adherent cells
were washed repeatedly and equilibrated in fresh MEM for 30 min
before addition of secretagogues and incubated for speciﬁed periods.
Stock solutions (×100) for phorbol myristate acetate (PMA) or calcium
ionophore A23187 were prepared in ethanol and diluted in MEM
before addition so that the incubation medium contained 0.1% ethanol.
Following indicated incubations, the medium was removed and the
cells harvested by scraping in homogenization buffer (50 mM Tris–
100 mM NaCl–0.5 mM EDTA–0.5 mM EGTA, pH 7.4) containingprotease and phosphatase inhibitors [1 mM PMSF, mixture of
leupeptin, pepstatin and aprotinin (each 5 μg/ml) and 1 mM Na
orthovanadate]. The cells were disrupted by sonication on ice (3×
10 s) followed by passage through 271/2G needle (×5) and the mem-
brane and the cytosol fractions were isolated by differential centrifuga-
tion (100,000 g for 60 min) where applicable.
2.3. Immunoprecipitation of SNAP23
Adherent cells were harvested by scraping in ice-cold non-
denaturing lysis buffer (50 mM Tris–HCl, pH 7.4, 0.3 M NaCl, 5 mM
EDTA, 0.02% Na azide and 1% Triton X-100) to which 10 mM
iodoacetamide, 1 mM PMSF and 2 μg/ml leupeptin were added before
use. All processing was done at or below 4 °C unless indicated. The sus-
pensionwas transferred to pre-cooled centrifuged tubes, vortexed gently
and allowed to further lyse on ice for at least 30 min. The suspensionwas
cleared by centrifugation (16,000g 15 min) and the supernatant used for
immuno-precipitation with SNAP23 antibodies to bacterially expressed
recombinant rat SNAP23 (see below) bound to protein A-Sepharose
beads (Sigma-Aldrich, St. Louis, MO) that were pre-treated with
preimmune serum before antibody binding. The antibody-bound beads
(10 μl) were incubated with bovine serum albumin (10 μl of 10%) to
block non-speciﬁc binding sites and then incubated for overnight with
end-over-end mixing after addition of the clariﬁed supernatant from
cell lysate. The beads were centrifuged (100 g for 150 s), washed with
lysis buffer (×4) and once with ice-cold phosphate-buffered saline. The
proteins bound to the beads were eluted and analyzed by immuno-
blotting using appropriate primary and secondary antibodies. To avoid
interference with the IgGs in the immuno-precipitate, the blots were
treated with (1:500) Clean-Blot IP Detection Reagent (Pierce), which
binds only to native (non-denatured) IgGs and allows their detection.
The western blots were probed with antibodies to recombinant rat A7
and SNAP23 proteins. The commercially available antibodies used for
immuno-staining of SNAP23, although suitable for IP experiments were
not suitable for western blots possibly because of poor reactivity with
denatured SNAP23.
2.4. Immuno-staining of cells
Studies for co-localization of two proteins by immunoﬂuorescence
staining were performed with type II cells cultured for 20–22 h on
glass cover slips. The cells adherent to cover slips were incubated
for indicated periods, washed and ﬁxed for 10 min in 4% paraformal-
dehyde. The cells were washed with phosphate-buffered saline (PBS)
and stored at 4 °C in PBS until processing. Prior to immuno-staining,
simultaneous blocking and permeabilization was performed for
30 min at room temperature in PBS containing 0.1% Triton X-100,
0.05% Tween20, 1% BSA and 5% donkey or goat serum. For staining
with antibodies in different species (A7 and ABCA3 or SNAP23 and
ABCA3), the cells were then incubated for overnight at 4 °C with anti-
bodies for A7 (1:500, custom-prepared) or SNAP23 (1:100, Synaptic
Systems, Göttingen, Germany), washed in PBS and incubated for 1 h
at room temperature with anti-rabbit Alexa488-conjugated secondary
antibodies (Invitrogen, Grand Island, NY). The staining for ABCA3 was
then performed by incubation for 1 h with monoclonal anti-ABCA3 an-
tibodies (1:500, Covance, Emeryville, CA) followed by 1 h incubation
with Alexa568-conjugated anti-mouse antibodies (1:500, Invitrogen,
Grand Island, NY). The immuno-stained cells were viewed in a confocal
laser scanning microscope. The protocol for immuno-staining using
rabbit polyclonal antibodies to SNAP23 and A7 was modiﬁed to avoid
cross-reactivity. Brieﬂy, the cells were ﬁxed for 10 min in 4% PFA,
washed, simultaneously blocked and permeabilized for 30 min. The
staining for ﬁrst antigen, SNAP23, was performed as discussed above.
Thereafter, the cells were washed and incubated for 30 min each
with biotin blocking agents (Invitrogen, Grand Island, NY), washed
and incubated for overnight with biotinylated rabbit anti-A7 antibodies
1798 T. Gerelsaikhan et al. / Biochimica et Biophysica Acta 1823 (2012) 1796–1806(1:500). Biotinylation of puriﬁed rabbit anti-A7 antibodies was
performed with ChromaLink Biotin One Shot antibody labeling kit
according to instructions (SoluLink, San Diego, CA). The cells were
washed and incubated for 1 h at room temperature with streptavidin-
AlexaFluor568 conjugated anti-rabbit antibodies (1:500). The nuclei
were counter-stained with DAPI for 1 min. The confocal scanning
microscopy for immuno-ﬂuorescence was performed after mounting
cover slips in anti-fade reagent (ProLong®, Invitrogen, Grand Island,
NY).
2.5. Bacterial expression GST-SNAP23 fusion protein
Rat lung cDNA library Zap-II (>2×106 total recombinants) (Strata-
gene, La Jolla, CA)was used as a template to amplify the coding sequence
for SNAP23 using the following primers. A sequential touchdown PCR
was carried out as follows. First, a forward primer (5′-cttaagagag-
tccaagagcagc-3′, Rat SNAP23, accession number NM_022689) and T7
reverse primer (5′-gtaatacgactcactatagggc-3′) were used to maximize
gene-speciﬁc ampliﬁcation of SNAP23-cDNA insert (94 °C for 5 min, 5
cycles 94 °C for 45 s, 70 °C for 45 s, 72 °C for 2 min). This was followed
by 5 cycles 94 °C for 45 s, 68 °C for 45 s, 72 °C for 2 min and 25 cycles
94 °C for 45 s, 66 °C for 45 s followed by 72 °C for 2 min. The PCR product
was gel-isolated and used as template for second PCR using both
SNAP23-speciﬁc primers with BamHI (forward: 5′ggtggaccgatgatcta-
tcaccagaagaaattc-3′) and EcoRI (reverse-5′-gtgaattcttagctgtcaatgagttt-
ctttgctc-3′) extensions, respectively. The PCR product was cloned into
pGEX-2T vector (Amersham Biosciences, GE Healthcare, Piscataway,
NJ) at the BamHI and EcoRI sites. The sequence and in frame insertion
was veriﬁed by sequencing. The construct was transformed into
Escherichia coli ER2566 and GST-SNAP23 fusion protein was puriﬁed as
previously described for GST-A7 fusion protein [28] and used for puriﬁ-
cation of recombinant GST-SNAP23 by binding to glutathione
Sepharose-4B beads (GE Healthcare, Piscataway, NJ). The expression of
SNAP23 protein was conﬁrmed by SDS-PAGE after thrombin (Roche
Diagnostics, Boehringer Mannheim, Germany) cleavage of the fusion
protein. The fusion protein was used for afﬁnity binding of A7 in type II
cell lysate or for in vitro binding of puriﬁed recombinant A7.
2.6. Puriﬁcation of recombinant SNAP23 and preparation of polyclonal
antibodies
The glutathione-Sepaharose4B bound GST-SNAP23 was treated
for 90 min at room temperature with thrombin (5 units/ml) in cleav-
age buffer (20 mM Tris, pH 7.2, 150 mM NaCl, 0.05% NP-40, 1 mM
CaCl2 and 0.01% β-mercaptoethanol). The reaction was stopped
with the addition of PMSF (1 mM, ﬁnal concentration), the beads
were separated by ﬁltration and the ﬁltrate was passed through col-
umns (HiTrap Benzamidine FF-high sub 1 ml column, GE Healthcare)
for removal of residual thrombin. The protein containing fractions
were pooled and dialyzed against PBS at 4 °C with three changes of
buffer after 12, 15 and 18 h. Thus puriﬁed SNAP23, which showed
one major protein followed by staining with Coomassie Blue-stained
SDS-PAGE, was used for preparation of rabbit polyclonal antibodies
through a commercial service (Covance).
2.7. In vitro GST pull-down assay
For afﬁnity binding studies, the glutathione Sepharose-4B beads
were washed (×3) with cold PBS and incubated overnight with end-
over-end rotation at 4 °C with GST-SNAP23 or GST (0.1 μM) in a total
volume of 500 μl of binding buffer (40 mM Hepes, pH 7.0, 100 mM
KCl, 1 mMEGTA, 2 mMMgCl2, 1% NP40 and 1 mMCaCl2) for protein(s)
binding.
Equal amounts of protein in cell lysates were precleared using GST-
bound Sepharose4B beads. The GST-SNAP23-bound beads were
washed (×6) with the binding buffer and incubated for overnightwith rotation with pre-cleared type II cell lysates (300–500 μg protein)
in the presence of indicated Ca2+ concentration buffered with 1 mM
EGTA at 4 °C. The Ca2+ concentrations in the binding reaction mixture
were determined after taking into consideration buffering with EGTA
or other ions and the effects of pH and the reaction temperature for
the binding assay, as originally described [29]. The calculations used
an open source program WinmaxC32 (http://maxchelator.stanford.
edu). Following binding, the beads were washed (×6) with the binding
buffer, centrifuged and boiled for 5 min in SDS sample buffer.
The beads were removed by centrifugation and the supernatant was
analyzed by western blot using A7 antibody (1:1000) and HRP-
conjugated secondary antibody (1:10,000 dilution).
2.8. In vitro binding of recombinant annexin A7 to GST-SNAP23
Direct interactions between SNAP23 and annexin A7 were investi-
gated in vitro in the absence or presence of Ca2+ (buffered with
1 mM EGTA). The binding reaction was carried out for 2 h at 4 °C in
binding buffer (40 mM Hepes, pH 7.0, 100 mM KCl, 1 mM EGTA,
2 mMMgCl2, 1% NP-40 and protease and phosphatase inhibitors) con-
taining 100 nM GST-SNAP23 bound to Sepharose4B beads and 200 nM
recombinant A7 and indicated concentrations of free calcium. The
reaction was stopped by centrifugation of beads to sequester bound
proteins. The beads were washed and the amounts of proteins quanti-
ﬁed by western blot analysis.
2.9. Annexin A7 phosphorylation and interactions with SNAP23
In vitro phosphorylation of recombinant annexin A7 with commer-
cially available PKC (EMD Biosciences, Philadelphia, PA) was carried
out as described previously [23]. Brieﬂy, the phosphorylation mixture
was incubated for 2 h at 30 °C (1 μg recombinant A7 in 10 μl reaction
volume) in the presence of 0.05 Units PKC, 4 μg phosphatidylserine,
100 nM PMA, 1 mM Na orthovanadate, 1 mM Ca2+ and 0.1 mM
ATP.MgCl2. The phosphorylation was stopped by placing tubes on ice
and with the addition of 1 mM EGTA to sequester Ca2+. In parallel re-
action, control phosphorylation reaction was conducted in the absence
of PKC or ATP. The in vitro binding to GST-SNAP23 was conducted for
2 h at 4 °C following 3-fold dilution of untreated annexin A7, non-
phosphorylated A7 or phosphorylated A7 according to the above-
described protocol.
2.10. Western blot analysis
Equal proportions of proteins eluted from beads or immuno-
precipitated proteins were resolved on SDS-PAGE (4–20%), transferred
to PVDF membranes, blocked with blocking solution containing 5%
bovine serum albumin or fat-free dry milk, and reacted with primary
antibodies (1:1000 dilution unless indicated). The membranes were
then reactedwith species-speciﬁc secondary antibodies (1:10,000 dilu-
tion) and the antigen(s) detected by chemiluminiscence using Super-
Signal® reagent (Pierce). Blots were imaged with a photo-imager
(Syngene USA, Frederick, MD).
2.11. Other analyses
Proteins were quantiﬁed according to Bradford [30] using protein-
binding dye reagent (Bio-Rad, Hercules, CA) and bovine-γ-globulin as
standard. Results of immuno-ﬂuorescence were analyzed after adjust-
ment of the ﬂuorescence intensities to the same range for individual
ﬂuorophore and the co-localization coefﬁcients (CC) were obtained
using the Zeiss LSM510, version 4.2 Program (Carl Zeiss Inc., Chester,
VA). The program analyzes each image to determine the total number
of co-localizing pixels above the threshold level in each channel to
calculate the CC. The weighted CC is calculated by normalizing the in-
tensity of co-localizing pixels in each channel with total pixel intensity
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in total ﬂuorescence intensity. Although these calculations are reliable
indicators of co-localization, further analysis of weighted CC from
several experiments was analyzed by ANOVA (for multiple groups) or
Student's t-test for independent observations (for two groups) with
GraphPad Prism (Version 5.00 for Windows, GraphPad Software, San
Diego, CA). For some of the studies, western blots were analyzed by
densitometry scanning of images (GeneTools software, Version 4.00,
Syngene USA, Frederick, MD). The results from several experiments
were analyzed for statistical signiﬁcance by ANOVA (for multiple
groups) or by Student's t-test (for two groups). In each case, Pb0.05
was considered signiﬁcant.
3. Results
3.1. A7 antibody
We have previously demonstrated that our puriﬁed antibody to re-
combinant annexin A7 recognizes a single band at ~47 kDa in lung,
24 h-cultured type II cells or in isolated lung lamellar bodies [23]. The
speciﬁcity of antibody was demonstrated by loss of reactivity following
pre-incubation with recombinant A7.A 
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3.2.1. Annexin A7 co-localization with SNAP23
We have previously demonstrated that stimulation of type II cells
with PMA, ATP, calcium ionophore or terbutaline, all established surfac-
tant secretagogues [2,3], increased membrane-association of cellular
A7. One of these membranes was determined to be lamellar bodies as
indicated by A7 co-localization with the marker protein, ABCA3 [23].
In the current study, we ﬁrst conﬁrmed that both PMA and A23187
increased the co-localization of A7 and ABCA3 in a time-dependent
manner (Fig. 1A). In each case, the co-localization coefﬁcient (CC) in-
creased with the incubation period. The values for weighted CC values
(i.e., normalized for total intensity) for each ﬂuorophore are shown in
individual panels. In parallel studies, isolated type II cells were incubat-
ed for up to 30 min with or without 100 nM PMA or 250 nM A23187
and the cells immuno-stained for SNAP23 and biotinylated A7
(Fig. 1B). The CC (0=no and 1=100% co-localization) for A7 in control
cells was 0.103, which increased to 0.121, 0.200 and 0.295 at 5, 15 and
30min, respectively, in A23187-treated cells. Similarly, the
corresponding CC values were 0.129, 0.118 and 0.245 in PMA-treated
cells. In this case also, the CC values weighted for the total intensity
for each ﬂuorophore are shown in each panel. Thus, the A7 co-15min 30min 
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is also present in the plasma membrane and lamellar bodies [20], our
studies showing co-localization of A7 and SNAP23 suggest that A7 traf-
ﬁcking toplasmamembrane is also associatedwith surfactant secretion.
This observation is in agreementwith previously reported in vitro bind-
ing of puriﬁed bovine A7 to the plasma membrane and lamellar body
fractions from cells stimulated with A23187 or PMA [22].3.2.2. Lamellar bodies targeted to t-SNARE domains
In the SNARE scheme of membrane fusion, syntaxin and SNAP, the
two t-SNARE proteins that primarily reside in the plasma membrane
together may form the acceptor site for the v-SNARE synaptobrevin
[10]. Our attempts to immuno-stain type II cells for synaptobrevin
did not show any staining (not shown). Therefore, we elected to
determine co-localization of ABCA3 with SNAP23 in control and
stimulated cells (Fig. 2). The cells were incubated for 30 min without
or with 100 nM PMA or 250 nM A23187, washed, ﬁxed and immuno-
stained for ABCA3 and SNAP23. In the control cells, SNAP23 wasmostly
localized to the extra-vesicular region and ABCA3was mostly vesicular,
presumably representing the lamellar body compartment. There was
some co-localization of the two proteins in the control cells, possibly
because of the presence of SNAP23 in lamellar bodies or because of
lamellar body docking at the plasma membrane during surfactant
secretion. In secretagogue-stimulated cells, the co-localization of two
proteins was greater because greater number of lamellar bodies
would localize close to the plasma membrane. Since cell-stimulation
is not likely to increase SNAP23 in lamellar bodies, the increased co-
localization of ABCA3 with SNAP23 was likely related to exocytosis of
lamellar bodies. These ﬁndings are in agreement with a previous report
suggesting a role for SNAP23 in lung surfactant secretion [20].Co
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Next, we investigated if PKC activation is required for A7 association
with SNAP23, similar to our previous observations showing A7 associ-
ation with the lamellar bodies [23]. For these studies, type II cells were
pre-incubated for 30 min with PKC inhibitor BisI (100 nM) and then
incubated for 30 min without or with 100 nM PMA or 250 nM
A23187. In cells pre-treated for 30 min with 100 nM BisI prior to
30 min incubation with indicated secretagogues, the co-localization of
annexin A7 with SNAP23was diminished in comparison to those with-
out the inhibitor (Fig. 3). As described above, further statistical compar-
ison of the weighted CC from several experiments (Fig. 3B) showed
increased co-localization of SNAP23 and A7 in A23187- and PMA-
stimulated cells. Further, PKC inhibition diminished the increased co-
localization of these two proteins in stimulated cells. In our previous
studies also, BisI similarly diminished the increased co-localization of
annexin A7 and ABCA3 in stimulated type II cells [23].
In parallel, we also investigated PKC regulation of SNAP23
and ABCA3 co-localization in stimulated type II cells (Fig. 4). In
these studies also, type II cells were pre-incubated for 30 min with
100 nM BisI before stimulation with PMA or A23187 for 30 min.
The immuno-ﬂuorescence analysis of cells showed increased co-
localization of SNAP23 and ABCA3 in stimulated cells, which was
diminished in cells pre-treated with BisI (Fig. 4A). Thus, the co-
localization of ABCA3 and SNAP23 was also dependent on PKC-
stimulated protein phosphorylation. The co-localization patterns
with weighted CC for each condition are shown in the lower panels.
Further statistical analysis of weighted CC from several experiments
showed that both PMA and A23187 increased the co-localization of
the two proteins in comparison to the controls (Fig. 4B). The increase
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Fig. 3. Increased co-localization of annexin A7 and SNAP23 in PMA- or A23187-treated cells is diminished by PKC inhibitor. Isolated rat type II cells were pre-incubated for 30 min
without or with 100 nM BisI before incubation for 30 min without or with 250 nM A23187 or 80 nM PMA. A. Fluorescence images show that prior treatment with BisI diminished
the increase in co-localization of A7 and SNAP23. The co-localization patterns for each group are shown in the lower panels and the numbers denote the weighted co-localization
coefﬁcient (CC) for individual ﬂuorophore in each image. A value close to zero indicates lack of co-localization. B. Graphic representation of weighted CC (mean±SE, n=3–5) with
statistical analysis (ANOVA) shows that both PMA and A23187 increased co-localization of two proteins in comparison to controls. Pretreatment with BisI caused diminished in-
crease in co-localization of both proteins in comparison to without BisI (Student's t-test). **Pb0.05 vs. control; *Pb0.05 vs. without BisI.
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Next, we determined direct interaction of A7 with SNAP23. In
vitro afﬁnity binding of bacterially expressed A7 (rA7) with GST-
SNAP23 fusion protein (Fig. 5A) bound to Sepharose 4B was mea-
sured in the presence of indicated concentrations of Ca2+ (Fig. 5B).The binding increased with increasing Ca2+. The negative control
(A7 binding to GST-beads) was conducted at slightly higher Ca2+
concentration (10 μM) to rule out even small amounts of binding.
In comparison to control (b30 nM, nominally zero Ca2+), the in-
crease in binding was clearly observed at 0.5 μM and higher Ca2+
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Fig. 4. Secretagogue-mediated increase in co-localization of ABCA3 with SNAP23 is blocked by PKC inhibitor. Isolated type II cells were treated for 30 min without or with 100 nM
BisI prior to 30 min incubation with 80 nM PMA or 250 nM A23187. The cells were ﬁxed and stained for SNAP23 and ABCA3 and the nuclei were counter-stained with DAPI.
A. Normalized images for green (SNAP23) and red (ABCA3) ﬂuorophores show that BisI pretreatment diminishes secretagogue-mediated increases in co-localization of two pro-
teins. The co-localization patterns and weighted co-localization co-efﬁcient (CC) for individual ﬂuorophore are shown in the lower panels for each image. B. Weighted CC from
4 to 6 experiments are plotted as mean±SE. **Pb0.05 in comparison to the controls (ANOVA) and *Pb0.05 in comparison to without BisI (Student's t-test).
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even at 5 μM Ca2+ (not shown).
The effect of PKC phosphorylation of rA7 on binding to SNAP23 was
investigated using afﬁnity binding with GST-SNAP23-Sepharose4B
beads. We and others have previously demonstrated that PMA andATP cause PKC activation in type II cells [31,32] and PMA causes PKC-
mediated phosphorylation of A7 in vitro and in vivo [18,23]. For pilot
studies, incubations of rA7 for phosphorylation reaction were con-
ducted for 2 h at 30 °C in the absence or presence of PKC or ATP. The
phosphorylated A7 was not puriﬁed from this incubation mixture.
Fig. 5. A7 binds to SNAP23 in calcium-dependent manner. A. Coomassie blue-stained
SDS-PAGE of recombinant A7 (rA7), GST-SNAP23 fusion protein and puriﬁed SNAP23
demonstrating the presence of a single major protein in each preparation. B. For in
vitro binding studies, rA7 was incubated for 2 h at 4 °C with Sepharose4B-bound re-
combinant GST-SNAP23 fusion protein or with GST in the presence of indicated Ca2+
concentrations buffered with 1 mM EGTA. The beads were washed extensively and
rA7 binding to beads detected by western blot analysis. The binding of A7 to SNAP23
was dependent on calcium concentrations. The last lane shows reaction with 45 ng
rA7 as a positive control.
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measure A7 binding to beads (Fig. 6A). The levels of bound A7were an-
alyzed by western blot analysis. The binding was unaffected by the
presence of only ATP or PKC, but was higher when rA7 was incubatedA
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Fig. 6. Phosphorylation of A7 increases its binding to SNAP23. A. Recombinant A7 was incuba
bound GST-SNAP23 fusion protein was evaluated in the presence of 100 μM Ca2+. The bindin
phosphorylated for 2 h without or with PKC and binding to Sepharose4B-bound GST-SNAP2
indicated Ca2+ concentrations. The binding of A7 was evaluated by western blot analysis. C.
mean±SE of protein (a.u., arbitrary units) on the blot. *Pb0.05 for non-phosphorylated
phosphorylated A7 at each Ca2+ concentration. Right panel. Densitometry analysis shows
two lanes in B).in complete phosphorylation mixture. Thus, phosphorylation of rA7 in-
creased its binding to SNAP23. The increased binding following PKC
phosphorylation of A7 was unlikely due to subsequent phosphorylation
of SNAP23, since the PKC enzyme and the co-factors were diluted
3-fold, the Ca2+ concentration was lowered from 1mM to that
indicated for the binding reaction by buffering with EGTA and, ﬁnally,
the binding reaction was conducted at 4 °C and not at 30 °C as routinely
used for PKC phosphorylation of A7. Next, we evaluated the binding of
phosphorylated rA7 to SNAP23 at different Ca2+ concentrations
(Fig. 6B). The binding results frommultiple experiments were evaluated
by densitometry scanning of western blots, which showed that PKC-
mediated phosphorylation increased A7 binding to SNAP23 at all con-
centrations of Ca2+ in this experiment (Fig. 6C) with similar amounts
of total A7 in the two reaction mixtures (Fig. 6C, right panel).
We also investigated the binding of cellular A7 to SNAP23, as mea-
sured by afﬁnity binding to GST-SNAP23-Sepharose 4B beads and by
immuno-precipitation (Fig. 7). For these studies, type II cells were in-
cubated for 30 min without or with 100 nM PMA. The cells were
washed and harvested by scraping in non-denaturing lysis buffer to
prepare cell lysate for immuno-precipitation. Afﬁnity binding using
Sepharose 4B-GST-SNAP23 showed increased binding of A7 from
PMA-treated cells in comparison to the control cells (Fig. 7A). The
A7 binding in PMA-treated cells was higher in the presence of 1 μM
Ca2+ than in the absence of Ca2+.
Because of poor western blot reactivity of commercially available
SNAP23 antibodies used above for immuno-staining studies (see
above), antibodies to recombinant SNAP23 antibodies (custom-
prepared) were employed for the studies described below. Western
blot analysis of homogenates from brain, lung and type II cells demon-
strated the presence of a single major band similar to that seen for the
recombinant SNAP23 (Fig. 7B). The speciﬁcity of antibodies was veriﬁed
by overnight pre-treatment of antiserum (10 μl) with puriﬁedrA
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cells for 30 min without orwith 80 nMPMA, the cell lysates were prepared and equal amounts of cell proteins were analyzed for A7 binding to Sepharose4B-bound GST-SNAP23 by pull-
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creased binding of A7 to SNAP23.
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western blot (Fig. 7B, right section) of recombinant SNAP23 (30 ng) or
samples of alveolar type II cells, lung or brain (50 μg protein, each). The
relative abundance, determined from SNAP23 to actin ratio, was
brain>type II cells>lung. The bacterially expressed recombinant pro-
tein showed slightly smaller size in comparison to the tissue protein
(Fig. 7B, arrow). These antibodies were then used for immuno-
precipitation studies with type II cells stimulated for 30 min without or
with 100 nM PMA. Immuno-precipitates with SNAP23 antibodies
showed increased levels of A7 in PMA-treated cells in comparison to
the control cells (Fig. 7C). Since A7 levels are normalized to SNAP23
levels, equal loading of SNAP23 on gels is not relevant. The densitometry
results from three different experiments are presented as the A7 to
SNAP23 ratio, which showed increased A7 co-precipitation with
SNAP23 (Fig. 7C, right panel) Thus, in vitro and in vivo evidence demon-
strates direct interaction between A7 and SNAP23, which is regulated by
Ca2+ and PKC-dependent phosphorylation of A7.4. Discussion
In this study, we provide new information on annexin A7 trafﬁcking
to SNAP23 domains in alveolar type II cells. The immuno-ﬂuorescence
co-localization studies showed that relocation of this membrane
fusion-promoting protein to SNAP23 domains increased following
cell-stimulation with PMA and A23187, two of the established secreta-
gogues of lung surfactant in alveolar type II cells. In parallel, these
agents also increased lamellar body trafﬁcking to SNAP23 domains as
demonstrated by increased co-localization of ABCA3 and SNAP23.
Together, these observations suggest that stimulation of surfactant se-
cretion is associated with A7 trafﬁcking and binding to SNAP23
domains.
The regulation of A7 or lamellar body trafﬁcking to SNAP23 domains
appears to be through protein phosphorylation. Our studies with BisI, a
speciﬁc inhibitor of PKC, showed diminished co-localization of A7 with
SNAP23 in secretagogue-stimulated cells (Fig. 3). The co-localization
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show PKC-dependence of increased co-localization for each protein in
stimulated type II cells. The BisI decrease of co-localization was higher
for A7 co-localization in PMA- and A23187-stimulated cells suggesting
that A7 phosphorylation was the primary determinant for relocation.
Activation and involvement of PKC in regulation of lung surfactant
secretion are amply demonstrated in several previous investigations
(reviewed in [1–3]). We have previously suggested a role for annexin
A7 in membrane fusion during surfactant secretion since this protein
increased surfactant secretion in permeabilized type II cells [5]. Our
previous [23] and present studies demonstrating BisI inhibition of A7
co-localization with SNAP23 and with lamellar bodies further suggest
PKC regulation of A7 function presumably in membrane fusion during
surfactant secretion. Thus, our co-localization studies allude to in-
creased trafﬁcking of A7 to the fusion site at the plasma membrane in
cells stimulated with secretagogues of lung surfactant.
The in vitro studies on binding of recombinant proteins suggest
direct interaction of A7 with SNAP23 that is regulated by the increase
in Ca2+ and in PKC activation. Annexin proteins share the common
property of calcium-dependent binding to phospholipid membranes
[33,34]. Therefore, calcium-dependence of A7 binding to SNAP23
(Fig. 5B) may be expected. However, the binding is also regulated by
phosphorylation of A7. Importantly, the binding of endogenous A7
(Fig. 7A) was higher even in the absence of Ca2+, suggesting that
other cellular factors could enhance A7 binding to SNAP23. These
studies also indicated additional regulation of interaction by Ca2+.
Thus, the Ca2+-dependence without or with phosphorylation is similar
for the recombinant and endogenous A7 and SNAP23 interactions. Ad-
ditionally, the afﬁnity binding studies with cell lysates suggest the
presence of excess pool of A7 that are not available for binding to
SNAP23 or lamellar bodies in intact cell, since A7 binding was greater
from lysates of PMA-stimulated cells and more A7 could be immuno-
precipitated with SNAP23 in comparison to that from control cells.
This pool of A7 is made available by cell lysis for in vitro binding.
Of the twomembers of annexin family, A2 and A7, reported to facil-
itate membrane fusion, the function of A7 is apparently regulated by
protein phosphorylation. Previous studies have demonstrated in vitro
and in vivo phosphorylation of A7 in isolated chromafﬁn cells [18]
and in alveolar type II cells [23]. The phosphorylation of recombinant
A7 can be achieved with several classes of commercially available
protein kinase enzymes, but only phosphorylation with PKC increased
its membrane aggregation property [18]. Although phosphorylation of
annexin A2 with PKC diminishes its membrane aggregation proper-
ties [35], it is likely that in vivo regulation of A2 is modulated by addi-
tional factors to overcome such inhibition. In case of A7 also, the
phosphorylation and membrane-association of A7 were demonstrated
to increase with both PKC and PKA activation in alveolar type II cells
[23].
The in vitro [22] and in vivo [23] membrane-association of A7 in
stimulated cells implies the presence of speciﬁc A7 binding domains
in the lamellar bodies and in the plasma membrane of type II cells.
Our current studies suggest that SNAP23 and possibly other
t-SNARE proteins could be present in these domains. The interaction
of A7 with the proteins of plasma membrane domains is apparently
augmented by A7 phosphorylation. However, a similar protein phos-
phorylation in the binding domains could also inﬂuence the observed
A7 relocation to SNAP23 domains. Our previous studies of in vitro bind-
ing of puriﬁed bovine A7 to plasma membrane and lamellar bodies
from PMA- or A23187-treated cells showing increased binding [22]
support such possibility. The phosphorylation of SNAP25 is critical for
NMDA receptor delivery and exocytosis at the cell surface [36].
Although SNAP 23 is implicated in surfactant secretion [20], the impor-
tance of its phosphorylation in type II cells is yet to be demonstrated. If
so, then protein phosphorylation (of SNAP23 and A7) process would be
even more critical in the regulation of lung surfactant secretion in type
II cells.We have previously suggested that some properties of A7 like in-
teraction with target and vesicle membranes and action as a Ca2+
sensor may be similar to those reported for synaptotagminI, one
[37] of the several SNARE-interacting proteins including calmodulin
[38], CaMKII [39], ENaC [40] and synaptophysin [41] (reviewed in
[42]). Except synaptotagminI, all other are reported to interact with
either the t- or the v-SNARE proteins [37,43]. In addition to inter-
acting with both the t- and v-SNARE proteins [44,45], synaptotagminI
has a critical function as Ca2+ sensor with the ability to insert into
membranes [46]. Similarly, A7 interacts with SNAP23 (a t-SNARE pro-
tein) in the plasma membrane and with lamellar bodies. The binding
to the two compartments is possibly at the exocytic sites to promote
membrane fusion, in co-operation with SNARE proteins. This specula-
tion is supported by the presence of Ca2+ and phospholipid binding
domains in A7 and in synaptotagmins [47,48] and because the two
proteins show similar properties of Ca2+-dependent membrane
aggregation and ability to interact with two types of biological or
synthetic membranes [6,49]. Also, similar to synaptotagminI action
as a Ca2+ sensor in synaptic transmission [47], A7 is postulated also
to act as Ca2+-dependent GTPase and could very likely function as a
Ca2+/GTP sensor [50,51] during lung surfactant secretion.
In conclusion, our in vivo and in vitro studies demonstrate the
regulation of A7 trafﬁcking to the plasma membrane compartment in
alveolar type II cells by Ca2+ and PKC-dependent mechanisms. Since
both processes are important in the regulation of lung surfactant secre-
tion and because of our previous observation of importance of A7 in
membrane fusion, we suggest that increased trafﬁcking of A7 to plasma
membrane is for augmentation of lung surfactant secretion. However,
conﬁrmation of precise role for A7 interactions with SNAP23 would
require additional studies establishing regulatory structural or phos-
phorylationmutants of A7 and their in vivo effects on regulated secretion
of lung surfactant.
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